Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02393755
Title Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Roswell Park Cancer Institute
Indications

colon adenocarcinoma

rectum adenocarcinoma

Therapies

Capecitabine + Nintedanib

Age Groups: adult
Covered Countries USA


No variant requirements are available.